
Master Capital Services analyst Ravi Singh recommended Aurobindo Pharma, Balkrishna Industries, and Mahindra & Mahindra for Samvat 2083.
Balkrishna Industries announced a dividend of ₹4 per equity share, setting November 11 as the record date.
Aurobindo Pharma declared a dividend of ₹11 per share with a face value of Re 1, also fixing November 11 as the record date.